Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 12,500 shares at $136.49 ($1.7M) on 2015-08-03, disclosed to the SEC on 2015-08-05.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.49 | 3,200 | $437K | 25.5% |
| 2 | $137.26 | 6,500 | $892K | 52.0% |
| 3 | $138.22 | 2,700 | $373K | 21.7% |
| 4 | $138.98 | 100 | $14K | 0.8% |
| Total | $137.28 avg | 12,500 | $1.7M | 100% |
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |